Intra vesical gemcitabine (G) single agent as adjuvant chemotherapy in superficial transitional cell carcinoma (TCC) of the bladder: Final results

被引：0
|
作者：
Bounedjar, A.
Ferhat, R.
Smaili, F.
Bouzid, K.
机构：
[1] Anticanc Ctr, Blida, Algeria
[2] Pierre Marie Curie Ctr, Algiers, Algeria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5078
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Results at 5 years of intra vesical gemcitabine (G) single agent as adjuvant chemotheray in superficial transitional cell carcinoma (TCC) of the bladder
    Smaili, F.
    Bounedjar, A.
    Ferhat, R.
    Bouzid, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Intravesical gemcitabine (G) single agent as adjuvant chemotherapy in superficial transitional cell carcinoma (TCC) of bladder.
    Bouzid, K
    Ferhat, R
    Bounedjar, A
    Mahfouf, H
    Smaili, F
    Adjali, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 407S - 407S
  • [3] Evaluation of superficial bladder transitional cell carcinoma (TCC)
    不详
    [J]. JOURNAL OF ENDOUROLOGY, 2004, 18 : A38 - A38
  • [4] A phase I trial of intra-vesical gemcitabine in the treatment of recurrent superficial transitional cell carcinoma of the bladder.
    Maddineni, SB
    Sangar, V
    Betts, CD
    O'Flynn, KJ
    Clarke, NW
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 : S63 - S63
  • [5] Intravesical gemcitabine in management of BCG refractory superficial transitional cell carcinoma (TCC) of urinary bladder
    Mohanty, N. K.
    Nayak, R. L.
    Arora, R. P.
    Saxena, S.
    [J]. BJU INTERNATIONAL, 2007, 99 : 14 - 14
  • [6] Pharmacogenetics determinants of anticancer activity of intravescical gemcitabine in patients with superficial transitional cell carcinoma (TCC) of the bladder
    Verweij, Fabrizio
    Matel, Victor D.
    Scardino, Epifanio
    Rocco, Bernardo
    Musi, Gennaro
    Besana, Umberto
    Zambito, Stefano
    Pimentel, Marcelo
    Pedroso, Eduardo
    de Cobelli, Ottavio
    de Braud, Filippo
    Curigliano, Giuseppe
    Spitaleri, Gianluca
    Pece, Salvatore
    Danesi, Romano
    Mey, Valentina
    Giovanetti, Elisa
    Nanizzi, Sara
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 81 - 81
  • [7] Pharmacogenetics determinants of anticancer activity of intravescical gemcitabine in patients with superficial transitional cell carcinoma (TCC) of the bladder
    De Braud, Filippo
    Danesi, Romano
    Curigliano, Giuseppe
    Giovanetti, Elisa
    De Cobelli, Ottavio
    De Pas, Tommaso
    Mey, Valentina
    Spitaleri, Gianluca
    Pece, Salvatore
    Noberasco, Cristina
    Nannizzi, Sara
    Verweij, Fabrizio
    Renne, Giuseppe
    McVie, Gordon
    Del Tacca, Mario
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [8] Neoadjuvant paclitaxel (P), carboplatin (Ca) and gemcitabine (G) in patients with locally advanced transitional cell carcinoma (TCC) of the bladder: A final report.
    Smith, D. C.
    Mackler, N. J.
    Hussain, M. H.
    Dunn, R.
    Montie, J. E.
    Wood, D.
    Lee, C. T.
    Petrylak, D.
    Quinn, D.
    Vaishampayan, U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 226S - 226S
  • [9] ADJUVANT TOPICAL CHEMOTHERAPY VERSUS IMMUNOTHERAPY IN PRIMARY SUPERFICIAL TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    FLAMM, J
    BUCHER, A
    [J]. BRITISH JOURNAL OF UROLOGY, 1991, 67 (01): : 70 - 73
  • [10] Neo-adjuvant M-VAC chemotherapy and bladder preservation for muscle infiltrating transitional cell carcinoma (TCC) of the bladder
    Sternberg, C
    Pansadoro, V
    Lauretti, S
    Platania, A
    Giannarelli, D
    Rossetti, A
    DeCarli, P
    Cancrini, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1142 - 1142
12345